Iqirvo Equities

Pharmaceuticals
GENFIT Achieves FDA Approval Milestone with Ipsen's Iqirvo® for Primary Biliary Cholangitis Jun 11, 2024
Pharmaceuticals
Ipsen Achieves FDA Accelerated Approval for Iqirvo® as Innovative PPAR Treatment for Primary Biliary Cholangitis Jun 11, 2024